Table 5. Associations between Epicardial Adipose Tissue Volume and Extent of Plaque among those with any Plaque Present (Plaque score > 0).

	Coronary Artery Calcium N= 93		Non-Calcified Plaque Score N= 423		Calcified Plaque Score N= 259		Mixed Plaque Score N= 239		Total Plaque Score N= 545
	Effect estimate (SE)	p-value	Effect estimate (SE)	p-value	Effect estimate (SE)	p-value	Effect estimate (SE)	p-value	Effect estimate (SE)	p-value
Model 1	0.048(0.013)	<0.001	0.011(0.006)	0.06	0.010(0.009)	0.26	0.005(0.009)	0.54	0.021(0.007)	0.001
Model 2	0.038(0.014)	0.006	0.005(0.006)	0.46	0.004(0.01)	0.67	0.001(0.009)	0.95	0.008(0.007)	0.23
Model 3	0.042(0.015)	0.005	0.007(0.007)	0.31	0.004(0.01)	0.73	-0.005(0.01)	0.66	0.010(0.008)	0.17
Model 4	0.048(0.017)	0.004	0.004(0.008)	0.56	0.007(0.011)	0.53	-0.007(0.011)	0.53	0.008(0.008)	0.31

Linear Regression of natural log transformed plaque scores among those with any plaque present; estimate represents log-plaque score change per 10 units increase in epicardial adipose tissue volume. SE= standard error; Model 1- Adjusted for age, race and HIV serostatus; Model 2- Model 1 plus CAD risk factors; Model 3- Model 2 plus body mass index; Model 4- Model 2 plus abdominal visceral adipose volume. CAD risk factors include systolic blood pressure, antihypertensive medication use, diabetes mellitus, fasting glucose, fasting triglyceride, use of lipid-lowering medications, and smoking (pack-years).